What it's used for
May support clinically meaningful weight reduction.
Pen injectorWeight Loss · Pen injector
An FDA-approved tirzepatide injection for chronic weight management in eligible patients, alongside nutrition and physical activity changes.
$849 · Month Supply 12.5mg/weekly
Ships to all states except AL.
About this treatment
An FDA-approved tirzepatide injection for chronic weight management in eligible patients, alongside nutrition and physical activity changes. FDA approval applies to specific products and indications; your prescribed use may be off-label.
The science
Tirzepatide activates GIP and GLP-1 receptors involved in appetite, insulin release, and digestion. It can reduce appetite and food intake, but individual weight changes vary.
Your clinician considers your symptoms, medical history, and other medicines before prescribing. Follow-up helps assess your response and whether treatment remains appropriate.
Benefits & evidence
May support clinically meaningful weight reduction.
May help reduce appetite and food intake.
Ongoing care supports tolerability and long-term planning.
Individual results vary and are not guaranteed.
Your next steps
Pick your treatment, plan length and state, then check out.
Share your health history and goals in a secure online form.
A licensed clinician reviews your intake, orders any required labs and decides if treatment is right for you.
If approved, your medication ships discreetly, with follow-up care along the way.
Safety information
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, and reduced appetite.
Do not use with a personal or family history of medullary thyroid carcinoma or MEN2; avoid during pregnancy and discuss pancreatitis, gallbladder disease, severe gastroparesis, and diabetes medicines. Seek prompt care for severe persistent abdominal pain, dehydration, or allergic symptoms. Oral contraceptive users need a nonoral method or added barrier protection for four weeks after starting and each dose increase.
This is an FDA-approved medication. Some uses may be off-label; your clinician decides whether it is appropriate for you.
Stop and contact your care team if you have a severe reaction. For a medical emergency, call 911.
Frequently asked questions
Inject once weekly as prescribed and follow pen instructions. Do not combine with another tirzepatide product or a GLP-1 receptor agonist.
Follow your clinician's review schedule. Contact them sooner for persistent side effects, worsening symptoms, or concerns about your response.
Follow the dispensing label for temperature, light protection, and discard dates. Ask your pharmacist before using medicine stored incorrectly.
It can ship to every state except Alabama.
Treatment is only prescribed when a licensed clinician decides it is appropriate. If it isn't, your care team will explain why and talk through other options.